Form D · Other
PROBIUSDX, INC.
Fremont, CA · CIK 0002083471
Offering snapshot reported Aug 26, 2025 · SEC filing
- Reported sold
- $2.44M Offering amount: $25M
- Investors reported
- 21 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 7, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 26, 2025 | Initial | $2,435,000 | No comparison | 21 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $252K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-555879
Source: Form D, filed Aug 26, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Chaitanya Gupta | Director, Executive |
| Emmanuel Quevy | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
48389 Fremont Blvd Suite 114
Fremont, CA, 94538
Fremont, CA, 94538